Trial intelligence / Profile preview

Interferon Alpha and Etoposide in Relapsed Osteosarcoma

NCT00504140Phase 2Completed

Sponsor
University of Texas MD Anderson Cancer Center
Start
Nov 1996
Primary completion
Nov 2007
Modality
Cytokines & Interferons
Countries
1
01

Overview

A Phase 2 trial of interferon alfa in osteosarcoma (OS), sponsored by University of Texas MD Anderson Cancer Center. Started Nov 1996; status: completed.

02

Drugs

interferon alfa
03

Conditions

osteosarcoma (OS)

Beyond the preview

Go deeper on NCT00504140.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00504140.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call